Biologics

Innovasis enters partnership to expand into biologics market: 5 insights

Spinal device company Innovasis partnered with Stability Biologics to enter the biologics market. By Shayna Korol - 11/19/18
FDA warns biologics company about illegally manufacturing stem cell products: 5 insights

The FDA warned StemGenex Biologic Laboratories about illegally marketing an unapproved stem cell product produced in a facility with significant manufacturing violations, putting patients at risk. By Shayna Korol - 11/16/18
4 things to know about CollPlant

CollPlant is a regenerative medicine company focused on 3D bioprinting tissues and organs and developing orthobiologics. By Shayna Korol - 11/15/18
SpinalCyte's CybroCell injections led to sustained improvement in clinical study: 5 notes

SpinalCyte reported positive 12-month endpoint MRI outcomes in a clinical study of its CybroCell injection for degenerative disc disease. By Shayna Korol - 11/15/18
Researchers use stem cells to create personalized implants with low risk of rejection: 3 things to know

Tel Aviv (Israel) University researchers generated functional spinal cord, cardiac, cortical and adipogenic tissue implants from personalized hydrogels, according to results detailed in Advanced Materials. By Shayna Korol - 11/14/18
3 things to know about Cellect Biotechnology

Cellect Biotechnology is a regenerative medicine company. By Shayna Korol - 11/13/18
Bio2 Technologies to begin enrolling patients in cervical interbody fusion device trial: 3 insights

Bio2 Technologies received FDA approval to begin enrolling patients in an investigational device exemption clinical study to evaluate Vitrium as a cervical interbody fusion device. By Mackenzie Garrity - 11/13/18
3 things to know about Kuros Biosciences' CEO

Joost de Bruijn, PhD, is the CEO of Kuros Biosciences. By Shayna Korol - 11/12/18
3 things to know about Histogenics

Histogenics develops restorative cell therapies for orthopedic pain relief. By Shayna Korol - 11/9/18
Imagion Biosystems incorporates 'printer & ink' business model for medical imaging

Imagion Biosystems is commercialising a form of medical imaging which uses biosafe nanoparticles to detect cancer, according to Proactive Investors Australia. By Shayna Korol - 11/8/18
SpinalCyte receives additional patents: 3 takeaways

Regenerative medicine company SpinalCyte was issued new patents in Hong Kong and Europe. By Mackenzie Garrity - 11/8/18
3 things to know about Lattice Biologics' CEO

Guy Cook is the CEO of Lattice Biologics. By Shayna Korol - 11/7/18
Cellect receives patent approval for Apograft technology: 3 notes

Cellect Biotechnology received several patent grants for its Apograft technology. By Shayna Korol - 11/6/18
OsteoRemedies unveils 1st FDA-cleared dual-antibiotic spacer & bone cement: 3 notes

OsteoRemedies launched the first FDA-cleared dual-antibiotic spacer system and bone cement offering with gentamicin and vancomycin. By Shayna Korol - 11/2/18
MTF Biologics & Academy Medical join forces to bring allografts to the VA: 4 notes

MTF Biologics and Academy Medical partnered to bring human allograft tissues to Veteran Affairs medical centers across the U.S. By Shayna Korol - 11/2/18
ORTHOReBIRTH USA & neurosurgeon partner to develop biologic solutions: 3 notes

ORTHOReBIRTH USA signed a letter of intent to develop new biologic products with Loubert Suddaby, MD. By Shayna Korol - 11/2/18
5 things to know about Tobra Medical’s Bone Basket

The Tobra Medical Bone Basket is designed to help surgeons maximize the collection of autologous bone during drilling for bone graft. By Shayna Korol - 11/1/18
Dr. Sunny Patel performs 1st MACI case at North Carolina hospital: 4 notes

Orthopedic surgeon Sunny Patel, MD, performed a new knee cartilage replacement procedure at Burlington, N.C.-based Alamance Regional Medical Center, the Times-News reports. By Shayna Korol - 10/31/18
Through StemExpress partnership, Biological Industries USA adds human mesenchymal cells to portfolio: 3 notes

Biological Industries USA and StemExpress partnered to distribute StemExpress' human bone marrow-derived mesenchymal stem cells. By Shayna Korol - 10/31/18
Burst Biologics' umbilical cord blood-derived product is a promising option for spinal fusion, study finds

Cytokines present in umbilical cord blood-derived products can stimulate cellular processes necessary for bone regeneration, according to a study in Regenerative Medicine. By Shayna Korol - 10/30/18

Page 1 of 50

«
Prev
1
2
3
4
5
6
7
8
9
10
Next
»

Top 40 Articles from the Past 6 Months